Aclaris Therapeutics Inc (ACRS) — Cash Flow Reinvestment Rate
Latest as of September 2024:
0.13x
Aclaris Therapeutics Inc (ACRS) has a Cash Flow Reinvestment Rate of 0.13x as of September 2024, reinvesting $2.79 Million (capex $0.00 plus investments $2.79 Million) from operating cash flow of $22.00 Million. See ACRS free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.13x
(Capex + Investments) / Operating CF
Total Reinvested
$2.79 Million
Capex + Investments
Operating Cash Flow
$22.00 Million
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Aclaris Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Aclaris Therapeutics Inc. See ACRS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow